Vesper Bio ApS
32879861ActiveA clinical-stage biotech company developing oral therapies for neurodegeneration.
Översikt
- 7
- Anställda
- Okänt
- Omsättning
- 2010
- Grundat
Nyckelbeslutsfattare
Anders Nykjær
Founder
Jacob Falck Hansen
Chief Executive Officer
John King-Underwood
Medicinal Chemistry
Graham Wynne
Medicinal Chemistry
+1 fler kontakter i Funnelfeedr
Beskrivning
Vesper Bio is a clinical-stage biotechnology company dedicated to pioneering research in Sortilin biology. The organization focuses on developing innovative oral therapies for patients suffering from devastating and fatal disorders, specifically targeting Frontotemporal Degeneration. Founded on deep...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- APS
- Momsnummer
- DK32879861
Beslutsfattare
5 kontakter i FunnelfeedrAnders Nykjær
Founder
Jacob Falck Hansen
Chief Executive Officer
Övriga kontakter
John King-Underwood
Medicinal Chemistry
Graham Wynne
Medicinal Chemistry
Andy Mulvaney
Business Development
Liknande företag
20 liknande företag i FunnelfeedrNeumirna Therapeutics ApS
9 anställdaDeveloping miRNA-based therapies to treat complex neurological disease root causes.
CONTERA PHARMA A/S
19 anställdaDanish biotech company developing innovative RNA therapeutics for neurological disorders.
Vertanical Denmark ApS
23 anställdaInnovative biopharmaceutical company developing advanced cannabinoid-based chronic pain therapies.
Pephexia Therapeutics ApS
5 anställdaDeveloping innovative peptide-based therapies for treating cachexia and sarcopenia.
PAREXEL DENMARK A/S
20 anställdaLeading global clinical research organization accelerating life-changing medical treatments worldwide.
Utforska mer
Frågor om Vesper Bio ApS
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo